| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 30 Jun 2025 | 24 Jun 2025 |
| Astec Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2025 ,inter alia, to consider and approve to consider, discuss and decide various matters in connection with the Rights Issue, including the specific terms of the Rights Issue, such as the determination of the Rights Issue price and related payment mechanism, rights entitlement ratio, the record date, timing of the Rights Issue and other terms and conditions with respect to the Rights Issue, subject to the receipt of in-principle approval from the stock exchanges or such other regulatory authorities as may be required Please find enclosed the Outcome of the Board Meeting held on Monday, June 30, 2025. Rights entitlement ratio: The Rights Equity Shares are being offered on a rights basis to Eligible Equity Shareholders in the ratio of 1 (One) Rights Equity Share for every 7 (Seven) fully paid-up Equity Shares held on the Record Date i.e., 4th July, 2025. (As Per BSE Announcement Dated on 30.06.2025) | ||
| Board Meeting | 24 Jun 2025 | 19 Jun 2025 |
| Astec Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/06/2025 inter alia to consider and approve fund raising The Board has considered and approved the raising of funds through Rights Issue of Equity shares. The Board has considered and approved raising of funds through Rights Issues of Equity Shares. The Board has considered and approved the raising of funds through Rights Issues of Equity Shares. (As Per BSE Announcement Dated on 24.06.2025) | ||
| Board Meeting | 23 Apr 2025 | 15 Apr 2025 |
| Astec Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/04/2025 ,inter alia, to consider and approve Please find enclosed intimation of Board Meeting to be held on Wednesday, 23rd April, 2025. Please find enclosed the Audited Financial Results of the Company for the Quarter and Financial Year ended March 31, 2025. Please find enclosed the Outcome of the Board Meeting held on April 23, 2025. (As Per Bse Announcement Dated on :23.04.2025) | ||
| Board Meeting | 28 Mar 2025 | 28 Mar 2025 |
| Please find enclosed Outcome of the Board Meeting held on 28th March, 2025. | ||
| Board Meeting | 27 Jan 2025 | 20 Jan 2025 |
| Quarterly Results ASTEC LIFESCIENCES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2025 ,inter alia, to consider and approve Kindly find enclosed the prior intimation of the Company. Please find enclosed intimation for conduct of Postal Ballot for seeking Approval of Shareholders for Re-appointment of Independent Director. Please find enclosed the intimation of proposed acquisition of 26% Equity shareholding in proposed Special Purpose Vehicle (As per BSE Announcement Dated on 27/01/2025) | ||
| Board Meeting | 25 Oct 2024 | 9 Oct 2024 |
| ASTEC LIFESCIENCES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/10/2024 inter alia to consider and approve Kindly find enclosed the prior intimation of the Company. Please find enclosed outcome of the Board Meeting dated October 25, 2024 (As per BSE Announcement Dated on 25/10/2024) | ||
| Board Meeting | 29 Jul 2024 | 18 Jul 2024 |
| ASTEC LIFESCIENCES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2024 inter alia to consider and approve Intimation of Board Meeting as per Regulations 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 Kindly find enclosed the Outcome of the Board Meeting held on Monday, July 29, 2024. Kindly find enclosed the Outcome of Board Meeting held on July 29, 2024. (As Per BSE Announcement dated on 29.07.2024) | ||
Here are some of the stocks that may see significant price movement today: CG Power, JK Cement, Reliance Infrastructure, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
